OMB APPROVAL
OMB Number: 3235-0287
Expires December 31, 2001
Estimated average burden
hours per response...........0.5
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[X] Check box if no longer subject of Section 16. Form 4 or Form 5 obligations
may continue. See Instruction 1(b).
________________________________________________________________________________
1. Name and Address of Reporting Person*
Credit Suisse First Boston,
on behalf of the investment banking business of
the Credit Suisse First Boston business unit
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
11 Madison Avenue
- --------------------------------------------------------------------------------
(Street)
New York NY 10010
- --------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
Charles River Laboratories International, Inc. (CRL)
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
________________________________________________________________________________
4. Statement for Month/Year
February 2002
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
________________________________________________________________________________
6. Relationship of Reporting Person to Issuer
(Check all applicable)
[_] Director [ ] 10% Owner
[_] Officer (give title below) [X] Other (specify below)
Transactions reported decreased
Reporting Person's ownership below
10%
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)
[X] Form filed by one Reporting Person
[_] Form filed by more than one Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code (D) and 4) (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 1,160,742 D 0 (I) (1)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 46,224 D 0 (I) (2)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 57,076 D 0 (I) (3)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 67,861 D 0 (I) (4)(13)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 25,200 D 0 (I) (5)(13)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 18,767 D 0 (I) (7)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 3,660 D 0 (I) (8)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 5,215 D 0 (I) (9)(14)(16)
(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 199,111 D 0 (I) (15)(16)(17)
(21)(23)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 130,793 D 0 (I) (16)(17)(19)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 12,791 A 25,750 (I) (24)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 121 A 244 (I) (25)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 11,031 A 22,047 (I) (26)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 15,780 A 46,555 (I) (27)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 15,780 A 46,555 (I) (28)(15)
(16)(17)(23)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 6 A 12 (I) (29)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 1,529 A 3,078 (I) (30)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 1,913 A 3,865 (I) (31)(13)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 917 A 1,856 (I) (32)(12)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 2,151 A 4,334 (I) (33)(14)(16)
(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 2/21/02 J 6,165 A 12,411 (I) (34)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 711,921 (I) (6)(15)
(16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 846,491 (I) (10)(14)(16)
(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 967,888 (I) (11)(14)(16)
(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 24,131 (I) (16)(17)(20)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 127,864 (I) (15)(16)(17)
(20)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 1,342 (I) (16)(17)(18)
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the Form is filed by more than one Reporting Person, see Instruction
4(b)(v).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.
SEC 1474 (3-99)
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
10.
9. Owner-
Number ship
of Form
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) (A) (D) cisable Date Title Shares 5) 4) 4) 4)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $5.19 Immed. 10/01/09 Common 26,247 3,455 (I) (10)(14)
Stock (16)(17)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $5.19 Immed. 10/01/09 Common 184,166 24,242 (I) (15)(16)
Stock (17)(21)
(23)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant $5.19 Immed. 10/01/09 Common 17,495 2,303 (I) (15)(16)
Stock (17)(22)
- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
(J) Shares of Common Stock of Charles River Laboratories International, Inc.
par value .01 per share ("Common Stock") were distributed to the partners
of the partnership on a pro-rata basis.
(1) These securities are held directly by DLJ Merchant Banking Partners II,
L.P. ("Partners II"), which is a partnership.
(2) These securities are held directly by DLJ Merchant Banking Partners II-A,
L.P., ("Partners II-A"), which is a partnership.
(3) These securities are held directly by DLJ Offshore Partners II, C.V.
("Offshore Partners II"), which is a partnership.
(4) These securities are held directly by DLJ Diversified Partners, L.P.
("Diversified"), which is a partnership.
(5) These securities are held directly by DLJ Diversified Partners-A, L.P.
("Diversified-A"), which is a partnership.
(6) These securities are held directly by DLJMB Funding II, Inc. ("Funding
II"), which is a Delaware corporation.
(7) These securities are held directly by DLJ Millennium Partners, L.P.
("Millennium"), which is a partnership.
(8) These securities are held directly by DLJ Millennium Partners-A, L.P.
("Millennium-A"), which is a partnership.
(9) These securities are held directly by DLJ EAB Partners, L.P. ("EAB"),
which is a partnership.
(10) These securities are held directly by DLJ ESC II, L.P. ("ESC II"), which
is a partnership.
(11) These securities are held directly by DLJ First ESC, L.P. ("ESC"), which
is a partnership.
(12) DLJ Merchant Banking II, Inc. ("MB II INC") is the Managing General
Partner of each of Partners II, Partners II-A, Millennium, and
Millennium-A and Advisory General Partner of Offshore Partners II. In
addition, DLJ Merchant Banking II, LLC ("MB II LLC") is the Associate
General Partner of each of Partners II, Partners II-A, Offshore Partners
II, Millennium, Millennium-A, and EAB. MB II INC is also the Managing
Member of MB II LLC.
(13) DLJ Diversified Partners, Inc. ("Diversified Partners") is the General
Partner of each of Diversified and Diversified-A. DLJ Diversified
Associates, L.P. ("Diversified Associates") is the Associate General
Partner of each of Diversified and Diversified-A. Diversified Partners is
also the General Partner of Diversified Associates.
(14) DLJ LBO Plans Management Corporation is the General Partner of EAB, ESC
and ESC II.
(15) Credit Suisse First Boston Private Equity, Inc. ("CSFBPE")is the sole
stockholder of each of MB II INC, Diversified Partners, Funding II, DLJ
Investment Funding, Inc. ("IP Funding") and DLJ Investment Partners, Inc.
(16) Credit Suisse First Boston (USA) Inc. ("CSFB-USA"), a Delaware corporation
formerly named Donaldson, Lufkin & Jenrette, Inc., is the parent of each
of DLJCC, CSFBPE and DLJ LBO Plans Management Corporation.
(17) In accordance with Securities and Exchange Commission Release No. 34-39538
(January 12, 1998), this Form 4 is being filed by Credit Suisse First
Boston (the "Bank"), a Swiss bank, on behalf of itself and its
subsidiaries, to the extent that they constitute part of the investment
banking business (the "Reporting Person") of the Credit Suisse First
Boston business unit (the "CSFB business unit"). The CSFB business unit is
also comprised of an asset management business ("Asset Management"). The
Reporting Person provides financial advisory and capital raising services,
sales and trading for users and suppliers of capital around the world and
invests in and manages private equity and venture capital funds. Asset
Management provides asset management and investment advisory services to
institutional, mutual fund and private investors worldwide. The address of
the Bank's principal business and office is Uetlibergstrasse 231, P.O. Box
900, CH 8070 Zurich, Switzerland. The address of the Reporting Person's
principal business and office in the United States is Eleven Madison
Avenue, New York, New York 10010.
The ultimate parent company of the Bank is Credit Suisse Group ("CSG"), a
corporation formed under the laws of Switzerland. CSG is a global
financial services company with two distinct business units. In addition
to the CSFB business unit, CSG and its consolidated subsidiaries are
comprised of the Credit Suisse Financial Services business unit. CSG's
business address is Paradeplatz 8, P.O. Box 1, CH 8070 Zurich,
Switzerland.
CSG, for purposes of the federal securities laws, may be deemed ultimately
to control the Bank and the Reporting Person. CSG, its executive officers
and directors, and its direct and indirect subsidiaries (including Asset
Management and the Credit Suisse Financial Services business unit) may
beneficially own shares of the securities of the issuer to which this
schedule relates (the "Shares") and such Shares are not reported in this
statement. CSG disclaims beneficial ownership of Shares beneficially owned
by its direct and indirect subsidiaries, including the Reporting Person.
The Reporting Person disclaims beneficial ownership of Shares beneficially
owned by CSG, Asset Management and the Credit Suisse Financial Services
business unit.
(18) These securities are held directly by DLJ Capital Corporation ("DLJCC"),
which is a Delaware corporation.
(19) These securities are held directly by Sprout Capital VIII, L.P. ("Sprout
VIII"), which is a partnership. DLJCC is the Managing General partner of
Sprout VIII.
(20) These securities are held directly by Sprout Venture Capital, L.P.
("Sprout"), which is a partnership. DLJCC is the general partner of
Sprout.
(21) These securities are held directly by DLJ Investment Partners, L.P.
("DLJIP"), which is a partnership.
(22) These securities are held directly by DLJ Investment Funding, Inc., a
Delaware corporation.
(23) DLJ Investment Partners, Inc. is the general partner of DLJIP.
(24) These securities are held directly by MB II LLC.
(25) These securities are held directly by DLJ MB II, INC.
(26) These securities are held directly by MB II INC.
(27) These securities are held directly by DLJ Investment Associates, L.P.,
which is a partnership, and itself a partner of DLJIP.
(28) These securities are held directly by DLJ Investment Partners, Inc.
(29) These securities are held directly by DLJ Offshore Management N.V. (DLJ
Off Mgt NV), which is a partner of Offshore Partners II.
(30) These securities are held directly by DLJ Strategic Partners, L.P., which
is a partnership, and itself a partner of Diversified.
(31) These securities are held directly by Diversified Partners.
(32) These securities are held directly by Diversified Associates.
(33) These securities are held directly by DLJ LBO Plans Management Corp.
(34) These securities are held directly by DLJ Venture Capital Partners, a
partner of Sprout VIII.
Credit Suisse First Boston, on behalf of the
investment banking business of the
Credit Suisse First Boston business unit
/s/ Ivy Dodes 03/11/02
- --------------------------------------------- ----------
By: Ivy Dodes Date
Managing Director
**Signature of Reporting Person
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB number.
